ACM Research (ACMR) EBITDA (2016 - 2026)

ACM Research (ACMR) has reported EBITDA for 11 consecutive years, with $49.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBITDA rose 56.95% year-over-year to $49.7 million in Q2 2026; TTM through Jun 2026 was $137.9 million, a 5.33% decrease from a year earlier, with the FY2025 full-year figure at $109.4 million, down 27.53% from the prior year.
• EBITDA was $49.7 million for Q2 2026 at ACM Research, up from $36.2 million in the prior quarter.
• Over five years, EBITDA peaked at $49.7 million in Q2 2026 and troughed at -$9.3 million in Q1 2022.
• A 5-year average of $27.8 million and a median of $29.7 million in 2023 frame the typical range for EBITDA.
• The widest YoY moves for EBITDA: up 362.6% in 2022, down 369.74% in 2022.
• Over 5 years, EBITDA stood at $16.7 million in 2022, then soared by 40.22% to $23.4 million in 2023, then surged by 88.2% to $44.0 million in 2024, then tumbled by 47.63% to $23.0 million in 2025, then surged by 115.95% to $49.7 million in 2026.
• The last three EBITDA figures came in at $49.7 million (Q2 2026), $36.2 million (Q1 2026), and $23.0 million (Q4 2025), per Business Quant data.